Moreover, Gab2 is selected by FRMT as the second discriminative protein in OV dataset, and this is in concordance with recent studies that reported Gab2 amplification and overexpression in a subset of primary high-grade serous ovarian cancers and cell lines [78]. Here, GAB2 is linked to ovarian serous adenocarcinoma.